Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Oct 19, 2026, 11:27 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Showing 1–24 of 439 matching trials from the live ClinicalTrials.gov search.

Filters: Condition: EXCRETION Clear all

Conditions: Surgery, Analgesics, Opioids
Interventions: In-home drug disposal pouch, Mail-in prepaid envelope; Other
Lead sponsor: University of Michigan; Other
Eligibility: 18 Years and older
Enrollment: 200 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2026
U.S. locations: 1
States / cities: Ann Arbor, Michigan

Conditions: Healthy
Interventions: [¹⁴C]Enlicitide chloride; Drug
Lead sponsor: Merck Sharp & Dohme LLC; Industry
Eligibility: 18 Years to 60 Years · Male only
Enrollment: 8 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2023
U.S. locations: 1
States / cities: Madison, Wisconsin

Conditions: Eosinophilic Esophagitis
Interventions: Novel Allergen-Specific Immune Signature Directed Approach to Dietary Elimination Therapy; Device
Lead sponsor: University of North Carolina, Chapel Hill; Other
Eligibility: 16 Years to 80 Years
Enrollment: 24 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2018
U.S. locations: 1
States / cities: Chapel Hill, North Carolina

Conditions: Healthy
Interventions: BI 207127 NA; Drug
Lead sponsor: Boehringer Ingelheim; Industry
Eligibility: 18 Years to 55 Years · Male only
Enrollment: 12 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2012
U.S. locations: 1
States / cities: Madison, Wisconsin

Conditions: Healthy
Interventions: Saroglitazar magnesium; Drug
Lead sponsor: Zydus Therapeutics Inc.; Industry
Eligibility: 18 Years to 55 Years · Male only
Enrollment: 8 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019
U.S. locations: 1
States / cities: Madison, Wisconsin

Conditions: Healthy Male Subjects
Interventions: KW-6356; Drug
Lead sponsor: Kyowa Kirin, Inc.; Industry
Eligibility: 18 Years to 65 Years · Male only
Enrollment: 8 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019
U.S. locations: 1
States / cities: Madison, Wisconsin

Conditions: Healthy Participants
Interventions: Quemliclustat; Drug
Lead sponsor: Arcus Biosciences, Inc.; Industry
Eligibility: 19 Years to 55 Years · Male only
Enrollment: 8 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2026
U.S. locations: 1
States / cities: Lincoln, Nebraska

Conditions: Bedwetting
Interventions: TENS; Device
Lead sponsor: Rajeev Chaudhry; Other
Eligibility: 5 Years to 18 Years
Enrollment: 27 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2016 – 2021
U.S. locations: 1
States / cities: Pittsburgh, Pennsylvania

Conditions: Erectile Dysfunction Following Radical Prostatectomy, Urinary Incontinence of Non-organic Origin
Interventions: Viberect device; Device
Lead sponsor: Johns Hopkins University; Other
Eligibility: 40 Years to 70 Years · Male only
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2019
U.S. locations: 2
States / cities: Baltimore, Maryland • Frederick, Maryland

Conditions: Sickle Cell Disease
Interventions: Questionnaire/Interview; Other
Lead sponsor: St. Jude Children's Research Hospital; Other
Eligibility: 6 Years to 17 Years
Enrollment: 250 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2016
U.S. locations: 1
States / cities: Memphis, Tennessee

Conditions: Gout, Hyperuricemia
Interventions: [14C] LC350189; Drug
Lead sponsor: LG Chem; Industry
Eligibility: 18 Years to 55 Years · Male only
Enrollment: 6 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2020
U.S. locations: 1
States / cities: Austin, Texas

Conditions: Healthy
Interventions: [14C]-ALXN2050; Drug
Lead sponsor: Alexion Pharmaceuticals, Inc.; Industry
Eligibility: 19 Years to 55 Years · Male only
Enrollment: 9 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2021
U.S. locations: 1
States / cities: Lincoln, Nebraska

Conditions: Non-Alcoholic Steatohepatitis
Interventions: SHP626, 5.95 μCi RAD; Drug · Radiation
Lead sponsor: Mirum Pharmaceuticals, Inc.; Industry
Eligibility: 18 Years to 50 Years · Male only
Enrollment: 8 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2015
U.S. locations: 1
States / cities: Madison, Wisconsin

Conditions: Insomnia
Interventions: PD 0200390; Drug
Lead sponsor: Pfizer; Industry
Eligibility: 18 Years to 65 Years
Enrollment: 6 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2008
U.S. locations: 1
States / cities: New Haven, Connecticut

Conditions: Healthy Volunteer
Interventions: [14C]CC-90001; Drug
Lead sponsor: Celgene; Industry
Eligibility: 18 Years to 55 Years · Male only
Enrollment: 8 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2020 – 2021
U.S. locations: 1
States / cities: Madison, Wisconsin

Conditions: Chronic Kidney Disease
Interventions: Control Food, Fiber Fortified Food; Other
Lead sponsor: University of Florida; Other
Eligibility: 18 Years and older
Enrollment: 15 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010
U.S. locations: 1
States / cities: Gainesville, Florida

Conditions: Respiratory Syncytial Virus Infections
Interventions: 200 mg RV521/78 µCi [ 14C]-RV521.; Drug
Lead sponsor: Pfizer; Industry
Eligibility: 18 Years to 55 Years · Male only
Enrollment: 9 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: Healthy Volunteers
Interventions: CC-122; Drug
Lead sponsor: Celgene; Industry
Eligibility: 18 Years to 55 Years · Male only
Enrollment: 6 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2014
U.S. locations: 1
States / cities: Madison, Wisconsin

Conditions: Tuberculosis
Interventions: PA-824; Drug
Lead sponsor: Global Alliance for TB Drug Development; Other
Eligibility: 19 Years to 50 Years · Male only
Enrollment: 6 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2006
U.S. locations: 1
States / cities: Madison, Wisconsin

Conditions: Carcinoma
Interventions: Systems-level intervention to promote colon cancer screening; Other
Lead sponsor: Washington University School of Medicine; Other
Eligibility: Not listed
Enrollment: 490 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2012 – 2017
U.S. locations: 1
States / cities: St Louis, Missouri

Conditions: Fecal Incontinence, Anal Incontinence
Interventions: Biodesign Tissue Repair Graft, Overlapping Sphincter Repair; Device · Other
Lead sponsor: Massarat Zutshi; Other
Eligibility: 18 Years and older · Female only
Enrollment: 13 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2014
U.S. locations: 1
States / cities: Cleveland, Ohio

Conditions: Spinal Cord Injuries, Constipation, Fecal Incontinence, Neurogenic Bowel
Interventions: Combination of Neostigmine and Glycopyrrolate, I-Box by Dynatronics; Drug · Device
Lead sponsor: James J. Peters Veterans Affairs Medical Center; Federal
Eligibility: 18 Years to 89 Years
Enrollment: 6 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2025
U.S. locations: 1
States / cities: The Bronx, New York

Conditions: Urinary Incontinence, Urinary Incontinence,Stress
Interventions: Adjustable Continence Therapy for Women (ACT); Device
Lead sponsor: Uromedica; Industry
Eligibility: 22 Years and older · Female only
Enrollment: 167 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2032
U.S. locations: 5
States / cities: Denver, Colorado • Meridian, Idaho • Independence, Missouri + 2 more

Conditions: Incontinence, Enuresis
Interventions: Underwear/Differential Reinforcement; Behavioral
Lead sponsor: University of Kansas; Other
Eligibility: 18 Months and older
Enrollment: 4 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2012 – 2013
U.S. locations: 1
States / cities: Lawrence, Kansas

Search by objective public record fields.

Methods for Effective Disposal of Surplus Analgesics to Facilitate Elimination

A Study to Evaluate the Metabolism, Excretion, and Mass Balance of [¹⁴C]Enlicitide Chloride ([¹⁴C]MK-0616) in Healthy Participants (MK-0616-016)

Application of a Novel Allergen-Specific Immune Signature Directed Approach to Dietary Elimination Therapy in Patients With Eosinophilic Esophagitis (IDiET)

Study Evaluating Absorption, Distribution, Metabolism and Excretion (ADME) of Single Dose [14C]-BI 207127 in Healthy Male Volunteers

Study to Evaluate Absorption, Metabolism and Excretion of Single-dose [14C]-Saroglitazar in Healthy Male Subjects

Phase 1, Open-label Study of the Absorption, Metabolism, and Excretion of [14C]-KW-6356

Metabolism, Excretion, and Mass Balance Study of Quemliclustat in Healthy Adult Participants (ARC-24)

Hand & Foot Nocturnal Enuresis TENS Study

Viberect Penile Vibratory Stimulation to Enhance Recovery of Erectile Function and Urinary Continence Post-Prostatectomy

Evaluation of Nocturnal Enuresis and Barriers to Treatment Among Pediatric Patients With Sickle Cell Disease

Mass Balance Study of [14C]LC350189 in Healthy Volunteers

Study of Radiolabeled ALXN2050 in Healthy Adult Males

A Study to Investigate How the Study Drug SHP626 is Eliminated From the Body After One Dose

A Study To Investigate The Absorption, Metabolism And Excretion Of [14C] PD 0200390 In Six Healthy Male Volunteers

Metabolism and Excretion of [14C]CC-90001 in Healthy Male Subjects

The Effects of Fiber Fortified Foods to the Diets of Chronic Kidney Disease Patients

A Study to Learn About Effect of Sisunatovir in Healthy Adult Male Participants

Radiolabeled Study of CC-122 in Healthy Subjects

A Study of the Safety, Tolerability, and Absorption, Metabolism, and Excretion of PA-824 in Healthy Adult Male Subjects.

Systems Intervention to Promote Colorectal Cancer (CRC) Screening

Comparison of the Efficacy of a Biological Implant to Reinforce Overlapping Sphincter Repair Versus Overlapping Sphincter Repair Alone

Neostigmine and Glycopyrrolate by Iontophoresis

Adjustable Continence Therapy (ACT) for the Treatment of Female SUI

Toilet Training Toddlers and Preschoolers